Lupin Confident Of US Growth On Tariff Mitigation, Rides High On Tolvaptan

Victoza Generic, Biosimilars Part Of US Growth Plan

 
• By Vibha Ravi
  
Business Growth Strategy
Lupin Is Optimistic Of US Growth Despite Challenges Like Tariffs (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business